• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    PDC Unveils New Brand Identity

    MD&M West News: Teamvantage Launches New Parent Company

    BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test

    Qosina Names Lee Pochter as Executive Vice President

    FDA Okays Early Feasibility Study for Anteris' TAVR Product
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Halkey-Roberts Corporation

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Halkey-Roberts Corporation

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System

    EAP given for the treatment of Stage III pancreatic cancer.

    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    The FDA has granted the Expedited Access Pathway designation to AngioDynamic’s NanoKnife System and proposed indication for use for the treatment of Stage III pancreatic cancer.
    Related Content
    • Secant Develops First Synthetic Regenerative Cardiovascular Graft
    • FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    • Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis
    • Vascular Dynamics Inc. Appoints New CEO
    • FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    Business Wire02.20.18
    AngioDynamics Inc., a provider of minimally invasive medical devices for vascular access, peripheral vascular disease, surgery, and oncology, announced that the U.S. Food and Drug Administration (FDA) has granted the Expedited Access Pathway (EAP) designation to the company’s NanoKnife System and proposed indication for use for the treatment of Stage III pancreatic cancer.
     
    The EAP program is designed to help patients gain more timely access to medical devices that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, for which no approved or cleared alternatives exist. This is achieved by expediting the device’s assessment and review processes through more interactive and timely communication with the FDA, pre- and post-market balance of data collection requirements, efficient and flexible clinical study design, FDA review team support and Agency senior management engagement, and priority review.
     
    Pursuant to the recently enacted 21st Century Cures Act, the FDA has released draft guidance for a Breakthrough Devices Program, which, when finalized, will supersede the EAP. The FDA has indicated that all devices that receive EAP designation will gain Breakthrough Device designation when the guidance document becomes final.
     
    Jim Clemmer, President and CEO of AngioDynamics, commented, “The Expedited Access Pathway and Breakthrough Devices Program is an important and meaningful initiative to prioritize review and approval for novel, innovative devices needed by patients for the treatment of life-threatening diseases and conditions. We are thrilled that the FDA has granted the EAP designation to NanoKnife for the treatment of Stage III pancreatic cancer and are excited to continue working with the FDA toward approval of NanoKnife as a treatment for the underserved patient population suffering from this deadly disease.”
     
    According to the American Cancer Society, pancreatic cancer is the third leading cause of cancer related deaths in the United States and is projected to increase to the second leading cause within the next five years. There are over 55,000 new cases and 44,000 estimated deaths in the US annually.1 The mortality rate is high due to the aggressive nature of the disease and lack of early warning signs. In fact, only 20 percent to 30 percent of patients are candidates for surgical resection at time of diagnosis.2 Approximately 40 percent percent of patients will present with Stage III and 40 percent with metastatic disease. Regardless of the stage of pancreatic cancer, it has the lowest survival rate of any cancer, with an overall one- and five-year survival rate of 27 percent and 8 percent, respectively.1
     
    There are limited treatment options for Stage III and IV disease, with chemotherapy and/or radiotherapy considered the standard of care.2 There have been advancements in both techniques, but this has come at the cost of greater toxicity,3 limiting the patients that are candidates for the treatment.
     
    The NanoKnife System has received 510(k) clearance from the FDA for the surgical ablation of soft tissue. The NanoKnife Ablation System utilizes low energy direct current electrical pulses to permanently open pores in target cell membranes. These permanent pores or nano-scale defects in the cell membranes result in cell death. The treated tissue is then removed by the body’s natural processes in a matter of weeks, mimicking natural cell death. Unlike other ablation technologies, NanoKnife Ablation System does not achieve tissue ablation using thermal energy.
     
    The NanoKnife Ablation System consists of two major components: a Low Energy Direct Current, or LEDC Generator and needle-like electrode probes. Up to six electrode probes can be placed into or around the targeted soft tissue. Once the probes are in place, the user enters the appropriate parameters for voltage, number of pulses, interval between pulses, and the pulse length into the generator user interface. The generator then delivers a series of short electric pulses between each electrode probe. The energy delivery is hyperechoic and can be monitored under real-time ultrasound.
     
    AngioDynamics provides minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. In the United States, the NanoKnife System has received a 510(k) clearance by the Food and Drug Administration for use in the surgical ablation of soft tissue, and is similarly approved for commercialization in Canada, the European Union and Australia. The NanoKnife System has not been cleared for the treatment or therapy of a specific disease or condition.

    References
    1. CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
    2. J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.
    3. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.
     
     
    Related Searches
    • ultrasound
    • u.s. food and drug administration
    • body
    • fda
    Suggested For You
    Secant Develops First Synthetic Regenerative Cardiovascular Graft Secant Develops First Synthetic Regenerative Cardiovascular Graft
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis
    Vascular Dynamics Inc. Appoints New CEO Vascular Dynamics Inc. Appoints New CEO
    FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    The Final Four: My Top Headlines for 2017 The Final Four: My Top Headlines for 2017
    Employee Feedback Should Be Part of a Product Safety Plan Employee Feedback Should Be Part of a Product Safety Plan
    Medtech Mettle: The 2017 Year in Review Medtech Mettle: The 2017 Year in Review
    FDA Commissioner Declares New Steps to Advance Medical Device Innovation FDA Commissioner Declares New Steps to Advance Medical Device Innovation
    FDA Warns Magellan Diagnostics of Possible Federal Law Violations FDA Warns Magellan Diagnostics of Possible Federal Law Violations
    ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the U.S. Market ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the U.S. Market
    FDA Approves First Test to Screen Zika Virus in Blood Donations FDA Approves First Test to Screen Zika Virus in Blood Donations
     FDA Grants ExThera Medical’s Seraph 100 Blood Filter Expedited Access Pathway Designation FDA Grants ExThera Medical’s Seraph 100 Blood Filter Expedited Access Pathway Designation
    Using Smartphone Using Smartphone 'Selfies' to Screen for Pancreatic Cancer
    FDA Warns US Stem Cell Clinic of Significant Deviations FDA Warns US Stem Cell Clinic of Significant Deviations

    Related Breaking News

    • Cardiovascular
      Secant Develops First Synthetic Regenerative Cardiovascular Graft

      Secant Develops First Synthetic Regenerative Cardiovascular Graft

      Supports regeneration of new vascular tissue structures without need for cell seeding or biologic growth promoters.
      Business Wire 01.16.18

    • Diagnostics
      FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit

      FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit

      Modified versions of BD Vacutainer blood collection tubes were marketed without FDA clearance or approval.
      U.S. Food and Drug Administration 01.12.18

    • Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis

      Second Sight Receives FDA Expedited Access Pathway Designation for Cortical Visual Prosthesis

      Orion converts images captured by a miniature video camera mounted on glasses into a series of small electrical pulses.
      Business Wire 12.05.17


    • Cardiovascular
      Vascular Dynamics Inc. Appoints New CEO

      Vascular Dynamics Inc. Appoints New CEO

      Ed Roschak joins VDI from NuVasive Specialized Orthopedics, where he served as CEO.
      GlobeNewswire 12.04.17

    • Diagnostics
      FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test

      FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test

      CMS also proposed coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers.
      U.S. Food and Drug Administration 12.01.17

    Loading, Please Wait..

    Trending
    • MO SCI Acquires Assets Of 3M’s Advanced Materials Business
    • Positive Long-Term Prospects For Japanese Diabetes Care Market
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • The Future Of Biomedical Engineering Advancements
    • Endologix Shares Positive 12-Month Results Of DETOUR-2 Trial
    Breaking News
    • PDC Unveils New Brand Identity
    • MD&M West News: Teamvantage Launches New Parent Company
    • BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test
    • Qosina Names Lee Pochter as Executive Vice President
    • FDA Okays Early Feasibility Study for Anteris' TAVR Product
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients
    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits
    ADM Expands Production to Meet Demand for Probiotics
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Reports Revenue Growth in 2022
    Orion Engineered Carbons Announces New Distribution Partnerships
    Personnel Changes at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    PDC Unveils New Brand Identity
    MD&M West News: Teamvantage Launches New Parent Company
    BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH Acquires MEDELPHARM to Strengthen R&D Product Line
    SRI Names Kathlynn Brown Biosciences Division President
    Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Kiss Colors & Care Taps Rapper JT as Brand Partner
    Revolution Beauty Expands into Walmart in the U.S.
    Macro-Environmental Factors Impacting the Packaging Industry
    Happi

    Latest Breaking News From Happi

    Perfect Corp. Receives MLPS 2.0-Compliant Status to Help Beauty and Fashion Brands Meet China's National Cybersecurity Standards
    Ocean Conservation Managers Convene for Fifth International Marine Protected Area Congress, Receives Private Sector Support From Mary Kay Inc.
    Mintel Reveals Macro-Environmental Factors Impacting Household and Personal Care Packaging
    Ink World

    Latest Breaking News From Ink World

    Orion Carbons Announces New Distribution Partnerships
    DuPont Reports 4Q, Full Year 2022 Results
    Graphic Packaging Reports Strong 4Q, Full Year 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    'Build Back the Wisconsin Paper Industry' event announced
    Magic Johnson to keynote Dscoop Edge St. Louis World Expo
    Norway's Digital Etikett grows with HP Indigo
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Edgewell’s Sales Increase
    Mitsui Chemicals, Asahi Kasei Combine Nonwovens Businesses
    Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OssDsign Launches New Product for Additional Surgical Procedures
    OSSIO Introduces Non-Permanent Compression Staple
    Dennis Jones Joins Intelivation Technologies as Manufacturing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv Expands NFC and HF Solutions Portfolio
    HID Acquires GuardRFID to Expand Healthcare Offering
    DuPont Reports Fourth Quarter, Full Year 2022 Results

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login